Exabis Library
Welcome to the e-CCO Library!
P514: Influence of the frequency of glucocorticosteroid therapy courses on the hormonal resistance in patients with ulcerative colitis.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P514: Optimising response to infliximab in the management of perianal Crohn’s disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P514: Serum levels of Klotho in inflammatory bowel disease: an exploratory study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P515 Comparability of upadacitinib pharmacokinetics in Japanese and non-Japanese subjects with ulcerative colitis with the extended-release formulation
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P515: A 12-week tailored physical training program including dietary advice in children with Inflammatory Bowel Disease: a randomized crossover trial
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P515: Costs associated with the management of refractory complex perianal fistulas in patients with Crohn's disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P515: Evaluation of treatment persistence of vedolizumab among Finnish inflammatory bowel disease patients in real-life clinical practice (FINVEDO)
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P515: Inflammatory bowel disease and malignancy – the outcome of patients with malignancy diagnosed before IBD diagnosis or IBD-targeted therapy
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P515: Infliximab desensitization in patients with Inflammatory Bowel Diseases: a safe therapeutic alternative
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P515: Manipulating the microbiome in paediatric acute severe colitis with a cocktail of antibiotics: A pilot randomised controlled trial
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P516 Daily consumers of drip-filtered coffee have a decreased risk of developing late-onset Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P516: Adrenal suppression in inflammatory bowel disease patients treated with glucocorticoids: a systematic review
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P516: Discrete choice experiment to examine patient preferences for surgical interventions in patients with Crohn’s perianal fistulas: results from a global burden of illness study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P516: Efficacy and safety of tofacitinib retreatment for ulcerative colitis after treatment interruption: Results from the OCTAVE clinical trials
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P516: Humoral immune responses to SARS-CoV-2 vaccines in an ozanimod open-label extension study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P516: Serological biomarkers of tissue remodeling are associated with endoscopic remission in Crohn’s disease patients treated with GED-0301 (mongersen)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P516: The use of first-line biologics in patients with ulcerative colitis in Norway from 2011 to 2016
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P517 A randomised, placebo-controlled pilot trial of faecal microbiota transplantation for paediatric Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P517: Activity assessment in ulcerative colitis: correlation analysis of endoscopic and histological scores
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P517: Features of cytomegalovirus infection in inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM